NCT01535872

Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients

Dehydroepiandrosterone Treatment for Poor Responders in IVF Patients: A Prospective Randomised Controlled Trial.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: KK Women's and Children's Hospital · Other Government
• Sex: Female
• Age: 21 Years – 42 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to show solid evidences of the efficacy of DHEA in improving the success rates of in-vitro fertilization (IVF) patients facing poor ovarian reserve.

Detailed description

Poor responders to IVF treatment occurs in 5-24% of in-vitro fertilisation (IVF) cycles, resulting in the cancellation of the cycle translating in very low pregnancy rate. Current interventions based upon the use of different stimulation regimen do not address the fundamental underlying physiological basis of follicular recruitment and development. The over-riding objective of this proposal is to devise novel therapeutic approaches to the treatment of poor responders of IVF treatment through dietary supplementation with Dehydroepiandrosterone (DHEA). The investigators hypothesise that DHEA supplementation leads to improvements in ovarian steroidogenesis in poor responders, leading to improved IVF outcome. Specifically, the investigators aim to 1. Conduct a prospective randomised controlled trial (RCT) on the effects of DHEA supplementation in women who are poor responders to IVF treatment. 2. Investigate the effects of DHEA supplementation on ovarian steroidogenesis and biochemical and ultrasonographic markers of ovarian reserves.

Conditions

• Infertility
• Poor Responder to IVF Treatment

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Dehydroepiandrosterone	DHEA in 25mg capsule. 1 capsule taken 3 times daily for up to 5 months.

Timeline

• Start date: 2012-02-01
• Primary completion: 2014-10-01
• Completion: 2017-11-01
• First posted: 2012-02-20
• Last updated: 2018-08-07

Locations

1 site across 1 country: Singapore